Trial Profile
Effects of Long-acting muscarinic antagonist(LAMA) and Long-acting beta-two-agonist (LABA) combination on dynamic pulmonary hyperinflation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2020
Price :
$35
*
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 09 Mar 2019 Planned number of patients changed from 50 to 38.
- 09 Mar 2019 Status changed from recruiting to completed.
- 03 Jun 2017 New trial record